Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 290

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Prevention of Cardiac Surgery–Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial

Zarbock, Alexander, Küllmar, Mira, Ostermann, Marlies, Lucchese, Gianluca, Baig, Kamran, Cennamo, Armando, Rajani, Ronak, McCorkell, Stuart, Arndt, Christian, Wulf, Hinnerk, Irqsusi, Marc, Monaco, Fabrizio, Di Prima, Ambra Licia, García Alvarez, Mercedes, Italiano, Stefano, Miralles Bagan, Jordi, Kunst, Gudrun, Nair, Shrijit, L’Acqua, Camilla, Hoste, Eric, Vandenberghe, Wim, Honore, Patrick M., Kellum, John A., Forni, Lui G., Grieshaber, Philippe, Massoth, Christina, Weiss, Raphael, Gerss, Joachim, Wempe, Carola, Meersch, Melanie·2021·Anesthesia & Analgesia

Abstract

BACKGROUND: Prospective, single-center trials have shown that the implementation of the Kidney Disease: Improving Global Outcomes (KDIGO) recommendations in high-risk patients significantly reduced the development of acute kidney injury (AKI) after surgery. We sought to evaluate the feasibility of implementing a bundle of supportive measures based on the KDIGO guideline in high-risk patients undergoing cardiac surgery in a multicenter setting in preparation for a large definitive trial. METHODS: In this multicenter, multinational, randomized controlled trial, we examined the adherence to the KDIGO bundle consisting of optimization of volume status and hemodynamics, functional hemodynamic monitoring, avoidance of nephrotoxic drugs, and prevention of hyperglycemia in high-risk patients identified by the urinary biomarkers tissue inhibitor of metalloproteinases-2 [TIMP-2] and insulin growth factor–binding protein 7 [IGFBP7] after cardiac surgery. The primary end point was the adherence to the bundle protocol and was evaluated by the percentage of compliant patients with a 95% confidence interval (CI) according to Clopper-Pearson. Secondary end points included the development and severity of AKI. RESULTS: In total, 278 patients were included in the final analysis. In the intervention group, 65.4% of patients received the complete bundle as compared to 4.2% in the control group (absolute risk reduction [ARR] 61.2 [95% CI, 52.6-69.9]; P < .001). AKI rates were statistically not different in both groups (46.3% intervention versus 41.5% control group; ARR −4.8% [95% CI, −16.4 to 6.9]; P = .423). However, the occurrence of moderate and severe AKI was significantly lower in the intervention group as compared to the control group (14.0% vs 23.9%; ARR 10.0% [95% CI, 0.9-19.1]; P = .034). There were no significant effects on other specified secondary outcomes. CONCLUSIONS: Implementation of a KDIGO-derived treatment bundle is feasible in a multinational setting. Furthermore, moderate to severe AKI was significantly reduced in the intervention group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1213/ane.0000000000005458

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 290

Metadata

Authors
Zarbock, A., Küllmar, M., Ostermann, M., Lucchese, G., Baig, K., Cennamo, A., Rajani, R., McCorkell, S., Arndt, C., Wulf, H., Irqsusi, M., Monaco, F., Di Prima, A. L., García Alvarez, M., Italiano, S., Miralles Bagan, J., Kunst, G., Nair, S., L’Acqua, C., Hoste, E., Vandenberghe, W., Honore, P. M., Kellum, J. A., Forni, L. G., Grieshaber, P., Massoth, C., Weiss, R., Gerss, J., Wempe, C., & Meersch, M.
Venue
Anesthesia & Analgesia
Published
2021-05-08
Volume
133
Issue
2
Pages
292-302
ISSN
0003-2999 (ISSN-L)
OpenAlex
W3133933796
Cited by
290
References
26
FWCI
26.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of Cardiac Surgery–Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. https://app.cochat.ai/papers/10.1213/ane.0000000000005458
The paper
Zarbock, A., Küllmar, M., Ostermann, M., Lucchese, G., Baig, K., Cennamo, A., Rajani, R., McCorkell, S., Arndt, C., Wulf, H., Irqsusi, M., Monaco, F., Di Prima, A. L., García Alvarez, M., Italiano, S., Miralles Bagan, J., Kunst, G., Nair, S., L’Acqua, C., . . . Meersch, M. (2021). Prevention of Cardiac Surgery–Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000005458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.